Blau Farmacêutica: Record net income and margin gains in 2024, with strong growth in all core segments

About this update from Blau Farmaceutica Sa

Record revenue and net income in 2024, with margin expansion and net debt reduction. Strategic investments in biotechnology and R&D support long-term growth and global expansion. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Blau Farmaceutica Sa